ADCY3 and type 2 diabetes mellitus: Grarup N., Moltke I., Andersen M.K., Dalby M., Vitting-Seerup K.,Kern T., Mahendran Y., Jørsboe E., Larsen C.V.L., Dahl-PetersenI.K., Gilly A., Suveges D., Dedoussis G., Zeggini E., PedersenO., Andersson R., Bjerregaard P., Jørgensen M.E., AlbrechtsenA., Hansen T. Loss-of-function variants in ADCY3 increase riskof obesity and type 2 diabetes.